Synonyms: peptide boronate | PS-341 | Velcade®
bortezomib is an approved drug (FDA (2003), EMA (2004))
Compound class:
Synthetic organic
Comment: Bortezomib is a dipeptide (Phe-Leu), with a pyrazinoic acid protecting the N-terminus and a boronic acid replacing the C-terminal carboxylic acid. The boron atom is believed to interact with and inactivate the catalytic site on β subunits which form the active core of the proteasome, preferentially binding β5 active site [4]. Bortezomib is the first-in-class proteasome inhibitor to be approved for clinical use.
Proteasome activity is reviewed in [3]. The compound also has antimalarial activity. The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification | |
Compound class | Synthetic organic |
Ligand families/groups | Antimalarial ligands |
Approved drug? | Yes (FDA (2003), EMA (2004)) |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
IUPAC Name |
[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid |
International Nonproprietary Names | |
INN number | INN |
8331 | bortezomib |
Synonyms |
peptide boronate | PS-341 | Velcade® |
Database Links | |
CAS Registry No. | 179324-69-7 |
ChEBI | CHEBI:52717 |
ChEMBL Ligand | CHEMBL325041 |
DrugBank Ligand | DB00188 |
DrugCentral Ligand | 391 |
GtoPdb PubChem SID | 178103007 |
PubChem CID | 387447 |
RCSB PDB Ligand | BO2 |
Search Google for chemical match using the InChIKey | GXJABQQUPOEUTA-RDJZCZTQSA-N |
Search Google for chemicals with the same backbone | GXJABQQUPOEUTA |
Search PubMed clinical trials | bortezomib |
Search PubMed titles | bortezomib |
Search PubMed titles/abstracts | bortezomib |
UniChem Compound Search for chemical match using the InChIKey | GXJABQQUPOEUTA-RDJZCZTQSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | GXJABQQUPOEUTA-RDJZCZTQSA-N |
Wikipedia | Bortezomib |